BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25891324)

  • 1. Does IL-22 protect against liver fibrosis in hepatitis C virus infection?
    Wu L; Zhao J
    Hepatology; 2015 Dec; 62(6):1919. PubMed ID: 25891324
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: To PMID 25476703.
    Sertorio M; Carmo RF; Cabantous S; Vasconcelos L; Pereira LB; Moura P; Dessein A
    Hepatology; 2015 Dec; 62(6):1920. PubMed ID: 25907639
    [No Abstract]   [Full Text] [Related]  

  • 3. IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections.
    Sertorio M; Hou X; Carmo RF; Dessein H; Cabantous S; Abdelwahed M; Romano A; Albuquerque F; Vasconcelos L; Carmo T; Li J; Varoquaux A; Arnaud V; Oliveira P; Hamdoun A; He H; Adbelmaboud S; Mergani A; Zhou J; Monis A; Pereira LB; Halfon P; Bourlière M; Parana R; Dos Reis M; Gonnelli D; Moura P; Elwali NE; Argiro L; Li Y; Dessein A
    Hepatology; 2015 Apr; 61(4):1321-31. PubMed ID: 25476703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver expression of IL-22, IL-22R1 and IL-22BP in patients with chronic hepatitis C with different fibrosis stages.
    de Brito RJVC; do Carmo RF; Silva BMS; Costa ACS; Rocha SWS; Vasconcelos LRS; Pereira LMMB; de Moura PMMF
    Cytokine; 2022 Feb; 150():155784. PubMed ID: 34920229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients.
    Ramzy I; Elsharkawy A; Fouad R; Hafez HA; El Raziky M; El Akel W; El-Sayed M; Khattab H; Shehata M; Elsharkawy M; Radwan A; Esmat G
    Acta Trop; 2017 Dec; 176():283-287. PubMed ID: 28851531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt.
    el-Shorbagy E; Afefy AF; Ibrahem IA; Mangoud AM; Eissa MH; Sabee EI; Mahrous S; Abdel-Monem A; Ismail A; Morsy TA; Etewa S; Nor Edin E; Mostafa Y; Abouel-Magd Y; el-Sedawy M; Ragab H; el-Tokhy H; Hassan MI; Lakouz K; Abdel-Aziz K; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):459-78. PubMed ID: 15124753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroscan of chronic HCV patients coinfected with schistosomiasis.
    Esmat G; Elsharkawy A; El Akel W; Fouad A; Helal K; Mohamed MK; Attia D; Khattab H; Doss W; Labib S
    Arab J Gastroenterol; 2013 Sep; 14(3):109-12. PubMed ID: 24206738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.
    Amiot L; Vu N; Rauch M; L'Helgoualc'h A; Chalmel F; Gascan H; Turlin B; Guyader D; Samson M
    J Hepatol; 2014 Feb; 60(2):245-52. PubMed ID: 24036009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations among the serum levels of some interleukins and the histopathological aspects in chronic viral hepatitis C.
    Avrămescu CS; Comănescu V; Popescu SN; Turculeanu A; Bălăşoiu M; Popescu CF; Lungulescu M
    Rom J Morphol Embryol; 2008; 49(1):57-62. PubMed ID: 18273504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C.
    Cachem FCOF; Dias AS; Monteiro C; Castro JR; Fernandes G; Delphim L; Almeida AJ; Tavares F; Maciel AMA; Amendola-Pires MM; Brandão-Mello CE; Bento CAM
    Immunology; 2017 Jun; 151(2):167-176. PubMed ID: 28140446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of fibrosis progression in hepatitis C infection: are genetics ready for clinical use?
    Wasmuth HE; Trautwein C
    J Hepatol; 2011 Jul; 55(1):3-4. PubMed ID: 21334397
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild alcohol consumption is not associated with increased fibrosis in patients with chronic hepatitis C.
    Cheung O; Sterling RK; Salvatori J; Williams K; Hubbard S; Luketic VA; Stravitz TR; Sanyal AJ; Contos MJ; Mills S; Shiffman ML
    J Clin Gastroenterol; 2011 Jan; 45(1):76-82. PubMed ID: 20818236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C.
    Wu LY; Liu S; Liu Y; Guo C; Li H; Li W; Jin X; Zhang K; Zhao P; Wei L; Zhao J
    Clin Immunol; 2015 May; 158(1):77-87. PubMed ID: 25771172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection.
    Becker VR; Badiani RG; Lemos LB; Perez RM; Medina-Pestana JO; Lanzoni VP; Ferreira AP; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1395-9. PubMed ID: 19525852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are cirrhosis and its complications inevitable in hepatitis C virus infection?
    Delahooke TE; Hayes PC
    Scott Med J; 2000 Apr; 45(2):35-7. PubMed ID: 10862433
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis and chronic viral hepatitis.
    Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
    Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.